Axin-mediated CKI Phosphorylation of Beta-catenin at Ser 45: a Molecular Switch for the Wnt Pathway

Overview

Journal Genes Dev

Specialty Molecular Biology

Date 2002 May 10

PMID 12000790

Citations 330

Authors

Sharon Amit

Ada Hatzubai

Yaara Birman

Jens S Andersen

Etti Ben-Shushan

Matthias Mann

Yinon Ben-Neriah

Irit Alkalay

Affiliations

Soon will be listed here.

Abstract

The Wnt pathway controls numerous developmental processes via the beta-catenin-TCF/LEF transcription complex. Deregulation of the pathway results in the aberrant accumulation of beta-catenin in the nucleus, often leading to cancer. Normally, cytoplasmic beta-catenin associates with APC and axin and is continuously phosphorylated by GSK-3beta, marking it for proteasomal degradation. Wnt signaling is considered to prevent GSK-3beta from phosphorylating beta-catenin, thus causing its stabilization. However, the Wnt mechanism of action has not been resolved. Here we study the regulation of beta-catenin phosphorylation and degradation by the Wnt pathway. Using mass spectrometry and phosphopeptide-specific antibodies, we show that a complex of axin and casein kinase I (CKI) induces beta-catenin phosphorylation at a single site: serine 45 (S45). Immunopurified axin and recombinant CKI phosphorylate beta-catenin in vitro at S45; CKI inhibition suppresses this phosphorylation in vivo. CKI phosphorylation creates a priming site for GSK-3beta and is both necessary and sufficient to initiate the beta-catenin phosphorylation-degradation cascade. Wnt3A signaling and Dvl overexpression suppress S45 phosphorylation, thereby precluding the initiation of the cascade. Thus, a single, CKI-dependent phosphorylation event serves as a molecular switch for the Wnt pathway.

Citing Articles

IGF1R activates FOXP3-β-catenin signaling to promote breast cancer development.

Li L, Zhang Z, Huang N, Ren J, Qin Y, Luo Y Breast Cancer Res Treat. 2025; .

PMID: 40055251 DOI: 10.1007/s10549-025-07663-0.

Diagnostic utility of LEF1 and β-catenin in WNT pathway tumors with CTNNB1 mutation.

Li C, Dong L, Zhu L, Guan W World J Surg Oncol. 2025; 23(1):30.

PMID: 39881334 PMC: 11776337. DOI: 10.1186/s12957-025-03675-8.

Exploration of degrons and their ability to mediate targeted protein degradation.

Harris Jr T, Trader D RSC Med Chem. 2025; .

PMID: 39867589 PMC: 11758578. DOI: 10.1039/d4md00787e.

Mechanistic insights into Wnt-β-catenin pathway activation and signal transduction.

Maurice M, Angers S Nat Rev Mol Cell Biol. 2025; .

PMID: 39856369 DOI: 10.1038/s41580-024-00823-y.

Disruption of the β-catenin destruction complex via Ephexin1-Axin1 interaction promotes colorectal cancer proliferation.

Kim J, Jeon Y, Chang I, Lee J, You H Exp Mol Med. 2024; 57(1):151-166.

PMID: 39741188 PMC: 11799323. DOI: 10.1038/s12276-024-01381-1.

References

Yamamoto H, Kishida S, Uochi T, Ikeda S, Koyama S, Asashima M . Axil, a member of the Axin family, interacts with both glycogen synthase kinase 3beta and beta-catenin and inhibits axis formation of Xenopus embryos. Mol Cell Biol. 1998; 18(5):2867-75. PMC: 110665. DOI: 10.1128/MCB.18.5.2867. View

Sparks A, Morin P, Vogelstein B, Kinzler K . Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res. 1998; 58(6):1130-4. View

YARON A, Hatzubai A, Davis M, Lavon I, Amit S, Manning A . Identification of the receptor component of the IkappaBalpha-ubiquitin ligase. Nature. 1998; 396(6711):590-4. DOI: 10.1038/25159. View

Wodarz A, Nusse R . Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol. 1999; 14:59-88. DOI: 10.1146/annurev.cellbio.14.1.59. View

Shibamoto S, Higano K, Takada R, Ito F, Takeichi M, Takada S . Cytoskeletal reorganization by soluble Wnt-3a protein signalling. Genes Cells. 1999; 3(10):659-70. DOI: 10.1046/j.1365-2443.1998.00221.x. View

Winston J, Strack P, Chu C, Elledge S, Harper J . The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro. Genes Dev. 1999; 13(3):270-83. PMC: 316433. DOI: 10.1101/gad.13.3.270. View

Latres E, Chiaur D, Pagano M . The human F box protein beta-Trcp associates with the Cul1/Skp1 complex and regulates the stability of beta-catenin. Oncogene. 1999; 18(4):849-54. DOI: 10.1038/sj.onc.1202653. View

Hart M, Concordet J, Lassot I, Albert I, del los Santos R, Durand H . The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr Biol. 1999; 9(4):207-10. DOI: 10.1016/s0960-9822(99)80091-8. View

Yamamoto H, Kishida S, Kishida M, Ikeda S, Takada S, Kikuchi A . Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3beta regulates its stability. J Biol Chem. 1999; 274(16):10681-4. DOI: 10.1074/jbc.274.16.10681. View

10.

Eastman Q, Grosschedl R . Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Curr Opin Cell Biol. 1999; 11(2):233-40. DOI: 10.1016/s0955-0674(99)80031-3. View

11.

Kitagawa M, Hatakeyama S, Shirane M, Matsumoto M, Ishida N, Hattori K . An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin. EMBO J. 1999; 18(9):2401-10. PMC: 1171323. DOI: 10.1093/emboj/18.9.2401. View

12.

Smalley M, Sara E, PATERSON H, Naylor S, Cook D, Jayatilake H . Interaction of axin and Dvl-2 proteins regulates Dvl-2-stimulated TCF-dependent transcription. EMBO J. 1999; 18(10):2823-35. PMC: 1171363. DOI: 10.1093/emboj/18.10.2823. View

13.

Kishida S, Yamamoto H, Hino S, Ikeda S, Kishida M, Kikuchi A . DIX domains of Dvl and axin are necessary for protein interactions and their ability to regulate beta-catenin stability. Mol Cell Biol. 1999; 19(6):4414-22. PMC: 104400. DOI: 10.1128/MCB.19.6.4414. View

14.

Lee J, Ishimoto A, Yanagawa S . Characterization of mouse dishevelled (Dvl) proteins in Wnt/Wingless signaling pathway. J Biol Chem. 1999; 274(30):21464-70. DOI: 10.1074/jbc.274.30.21464. View

15.

Li L, Yuan H, Weaver C, Mao J, Farr 3rd G, Sussman D . Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1. EMBO J. 1999; 18(15):4233-40. PMC: 1171499. DOI: 10.1093/emboj/18.15.4233. View

16.

Boutros M, Mlodzik M . Dishevelled: at the crossroads of divergent intracellular signaling pathways. Mech Dev. 1999; 83(1-2):27-37. DOI: 10.1016/s0925-4773(99)00046-5. View

17.

Hinoi T, Yamamoto H, Kishida M, Takada S, Kishida S, Kikuchi A . Complex formation of adenomatous polyposis coli gene product and axin facilitates glycogen synthase kinase-3 beta-dependent phosphorylation of beta-catenin and down-regulates beta-catenin. J Biol Chem. 2000; 275(44):34399-406. DOI: 10.1074/jbc.M003997200. View

18.

Bienz M, Clevers H . Linking colorectal cancer to Wnt signaling. Cell. 2000; 103(2):311-20. DOI: 10.1016/s0092-8674(00)00122-7. View

19.

Fearnhead N, Britton M, Bodmer W . The ABC of APC. Hum Mol Genet. 2001; 10(7):721-33. DOI: 10.1093/hmg/10.7.721. View

20.

Frame S, Cohen P, Biondi R . A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol Cell. 2001; 7(6):1321-7. DOI: 10.1016/s1097-2765(01)00253-2. View